Mesh.i
Checkpoint
Ncbi
Racine
Checkpoint
Ncbi
Exploration
Accueil
Racine
Racine

Serveur d'exploration Tocilizumab - Checkpoint (Ncbi)

Index « Mesh.i » - entrée « Flow Cytometry »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Flavonoids < Flow Cytometry < Fluconazole  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 15.
Ident.Authors (with country if any)Title
000349 (2011) Petra Roll [Allemagne] ; Khalid Muhammad ; Mathias Schumann ; Stefan Kleinert ; Hermann Einsele ; Thomas Dörner ; Hans-Peter TonyIn vivo effects of the anti-interleukin-6 receptor inhibitor tocilizumab on the B cell compartment.
000430 (????) A. Snir [Israël] ; A. Kessel ; T. Haj ; I. Rosner ; G. Slobodin ; E. ToubiAnti-IL-6 receptor antibody (tocilizumab): a B cell targeting therapy.
000476 (2011) Christoph Garbers [Allemagne] ; Wolfgang Thaiss ; Gareth W. Jones ; Georg H. Waetzig ; Inken Lorenzen ; Florence Guilhot ; Rami Lissilaa ; Walter G. Ferlin ; Joachim Grötzinger ; Simon A. Jones ; Stefan Rose-John ; Jürgen SchellerInhibition of classic signaling is a novel function of soluble glycoprotein 130 (sgp130), which is controlled by the ratio of interleukin 6 and soluble interleukin 6 receptor.
000569 (2012) Christophe Richez [France] ; Thomas Barnetche ; Liliane Khoryati ; Pierre Duffau ; Marie Kostine ; Cécile Contin-Bordes ; Patrick Blanco ; Thierry SchaeverbekeTocilizumab treatment decreases circulating myeloid dendritic cells and monocytes, 2 components of the myeloid lineage.
000630 (2013) Yuko Shirota [États-Unis] ; Cheryl Yarboro ; Randy Fischer ; Tuyet-Hang Pham ; Peter Lipsky ; Gabor G. IlleiImpact of anti-interleukin-6 receptor blockade on circulating T and B cell subsets in patients with systemic lupus erythematosus.
000990 (2014) Sudipto Das [Royaume-Uni] ; Edward M. Vital ; Sarah Horton ; Domini Bryer ; Yasser El-Sherbiny ; Andrew C. Rawstron ; Frederique Ponchel ; Paul Emery ; Maya H. BuchAbatacept or tocilizumab after rituximab in rheumatoid arthritis? An exploratory study suggests non-response to rituximab is associated with persistently high IL-6 and better clinical response to IL-6 blocking therapy.
000A05 (????) Giuliana Guggino [Italie] ; Anna Rita Giardina ; Stefania Raimondo ; Giuseppina Giardina ; Guido Sireci ; Francesco Dieli ; Marco Peralta ; Riccardo Alessandro ; Giovanni Triolo ; Francesco CicciaTargeting IL-6 signalling in early rheumatoid arthritis is followed by Th1 and Th17 suppression and Th2 expansion.
000C33 (2015) Hiroki Goto [Japon] ; Eriko Kudo ; Ryusho Kariya ; Manabu Taura ; Harutaka Katano ; Seiji OkadaTargeting VEGF and interleukin-6 for controlling malignant effusion of primary effusion lymphoma.
000C46 (2015) Anders Elm Pedersen ; Kim Holmstr M ; Flemming J Rgensen ; Simon S. Jensen ; Monika GadDevelopment of assay platforms for in vitro screening of Treg modulating potential of pharmacological compounds.
000D35 (2015) Konstantia-Maria Chavele [Royaume-Uni] ; Eve Merry [Royaume-Uni] ; Michael R. Ehrenstein [Royaume-Uni]Cutting edge: circulating plasmablasts induce the differentiation of human T follicular helper cells via IL-6 production.
001229 (2016) Songsong Li ; Zhenzhou Wu ; Ling Li ; Xuehua LiuInterleukin-6 (IL-6) Receptor Antagonist Protects Against Rheumatoid Arthritis.
001474 (2017) Tawfik Khoury [Israël] ; Vered Molho-Pessach [Israël] ; Yuval Ramot [Israël] ; Abu Rmeileh Ayman [Israël] ; Orly Elpeleg [Israël] ; Neville Berkman [Israël] ; Abraham Zlotogorski [Israël] ; Yaron Ilan [Israël]Tocilizumab Promotes Regulatory T-cell Alleviation in STAT3 Gain-of-function-associated Multi-organ Autoimmune Syndrome.
001556 (2017) Guillermo Carvajal Alegria ; Valérie Devauchelle-Pensec ; Yves Renaudineau [France] ; Alain Saraux ; Jacques-Olivier Pers [France] ; Divi CornecCorrection of abnormal B-cell subset distribution by interleukin-6 receptor blockade in polymyalgia rheumatica.
001785 (2017) Shuntaro Saito [Japon] ; Katsuya Suzuki [Japon] ; Keiko Yoshimoto [Japon] ; Yuko Kaneko [Japon] ; Yoshihiro Matsumoto [Japon] ; Kunihiro Yamaoka [Japon] ; Tsutomu Takeuchi [Japon]A new bioassay for measuring the strength of IL-6/STAT3 signal inhibition by tocilizumab in patients with rheumatoid arthritis.
001851 (2017) Sonja Dulic [Hongrie] ; Zs Fia Vásárhelyi [Hongrie] ; Florentina Sava [Hongrie] ; Lászl Berta [Hongrie] ; Balázs Szalay [Hongrie] ; Gergely Toldi [Hongrie] ; Lászl Kovács [Hongrie] ; Attila Balog [Hongrie]T-Cell Subsets in Rheumatoid Arthritis Patients on Long-Term Anti-TNF or IL-6 Receptor Blocker Therapy.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/Ncbi/Checkpoint

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Checkpoint/Mesh.i -k "Flow Cytometry" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Checkpoint/Mesh.i  \
                -Sk "Flow Cytometry" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Checkpoint/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    Ncbi
   |étape=   Checkpoint
   |type=    indexItem
   |index=    Mesh.i
   |clé=    Flow Cytometry
}}
Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021